• ASIA: +91-20-69018686
  • US: +1-646-491-9876
  • UK: +44-20-8125-4005
  • Toll Free: 1800 121 6455
  • Email : sales[at]theinsightpartners[dot]com

    Joint Pain Injection Market is expected to reach US$ 6,996.88 Mn by 2028

    Published Date: 30 Apr 2021

    Corticosteroid Segment to Lead Market During 2021–2028


    According to our new research study on “Joint Pain Injection Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Drug, Joint Type, and Distribution Channel,” the market is expected to reach US$ US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. The report highlights trends prevailing in the joint pain injection market and factors driving its growth. The growth of the joint pain injection market is mainly attributed to the factors such as the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.


    Based on drug, the joint pain injection market, by drug, is segmented into hyaluronic acid, corticosteroid, and others. The corticosteroid segment held the largest market share in 2020, and it is expected to register the highest CAGR during the forecast period. Corticosteroids offer quick pain relief and help treat inflammation, pain, swelling, and redness. Further, surge in number of product approvals and launches is a key factor contributing to the market growth of the corticosteroids segment. For instance, in 2017, FDA approved ZILRETTA, an extended-release corticosteroid for the treatment of osteoarthritis-related knee pain.


    Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx are among the leading companies operating in the joint pain injection market.


    Joint pain injection Market, by Region, 2019 (%)

    Joint pain injection Market, by Region, 2019 (%)

    Report : Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)


    The report segments the joint pain injection market as follows:


    By Drug

    • Hyaluronic Acid
    • Corticosteroid
    • Others

    By Joint Type

    • Knee
    • Foot and Ankle
    • Shoulder and Elbow
    • Hip
    • Others

    By Distribution Channel

    • Retail Pharmacies
    • Hospitals Pharmacies
    • Others

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Middle East and Africa (MEA)
      • Saudi Arabia
      • UAE
      • South Africa
      • Rest of Middle East and Africa
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of South and Central America

    Contact Us
    Contact Person: Sameer Joshi 
    Phone: +1-646-491-9876
    Email Id: sales@theinsightpartners.com  
    Download Free PDF Brochure